Quantcast

Latest Russell Budd Stories

2014-07-10 23:09:39

Talc Pleurodesis Offers Several Benefits Over Video-Assisted Method of Reducing Fluid Buildup in Lungs DALLAS (PRWEB) July 10, 2014 Researchers in the United Kingdom have found that a procedure that uses talc to help seal the lining of the lungs in patients suffering from pleural mesothelioma is superior to a video-assisted surgical procedure in reducing hospital stays and the occurrence of complications, the mesothelioma law firm of Baron and Budd reports. The results of the research...

2014-07-08 23:06:23

Copper-Enhanced Disulfiram Could Help Prevent Disease from Spreading DALLAS (PRWEB) July 08, 2014 A recent study indicates that a drug approved by the U.S. Food and Drug Administration (FDA) could help to not only enhance the effectiveness of chemotherapy in the treatment of mesothelioma, but could also help prevent the disease from spreading, reports the national law firm of Baron and Budd. The study was published in the April 2014 issue of PLOS ONE....

2014-07-02 23:04:06

Differentiation Between Malignant Pleural Mesothelioma and Non-Cancerous Conditions Can Help Enhance Chances for Survival DALLAS (PRWEB) July 02, 2014 The Journal of Molecular Diagnostics has published a study that could be a significant help in correctly diagnosing malignant pleural mesothelioma. The disease can be extremely difficult to distinguish from reactive mesothelial proliferations, a common issue that is non-cancerous. By being able to accurately differentiate between the two...

2014-06-19 23:09:52

Study Indicates Carboplatin Can Deliver Superior Performance When Compared to Other Chemotherapy Drugs Los Angeles, CA (PRWEB) June 19, 2014 A study conducted by a surgical team at Creighton University Medical Center in Omaha, Nebraska published April 8, 2014, has shown what researchers believe is the correct chemotherapy drug to use in conjunction with surgery in patients suffering from peritoneal mesothelioma, reports the national law firm of Baron and Budd. As a result, survival rates...

2014-06-11 23:07:15

Letter Cited Several Issues Found After Inspection of Company’s Minnesota Plant Dallas, TX (PRWEB) June 11, 2014 The national law firm of Baron and Budd reports that the Food and Drug Administration (FDA) issued a warning letter to American Medical Systems, a manufacturer of transvaginal mesh devices. The letter was in regard to issues the FDA found at a facility run by the company, including procedures involving risk analysis and process validation procedures. The parent company of...

2014-05-08 23:07:14

Thousands of Lawsuits Still Pending in Transvaginal Mesh Litigation DALLAS (PRWEB) May 08, 2014 Russell Budd, co-founder and managing shareholder of Baron and Budd, has been appointed to serve on the Plaintiffs’ Steering Committee (PSC) in the litigation surrounding issues with the transvginal mesh implant. This committee oversees all activity in the litigation on the plaintiffs’ side, meaning that Budd will take an active role in the protecting the rights of every woman who has...

2014-04-25 23:03:53

Baron & Budd Urges Women Affected to Call for Free Consultation Dallas, TX (PRWEB) April 25, 2014 Thousands of women throughout New Mexico and the United States received transvaginal mesh implants to treat pelvic organ prolapse and stress urinary incontinence during the last decade. Since 2008, the U.S. Food and Drug Administration (FDA) has received thousands of reports of transvaginal mesh erosion, failure and rejection. Baron and Budd shareholder and co-founder Russell Budd...

2014-04-24 23:04:31

Plaintiff Testifies She Had to Undergo 18 Subsequent Revision Surgeries After Mesh Implantation DALLAS (PRWEB) April 24, 2014 The national law firm of Baron and Budd reports that a New Jersey jury previously awarded an $11.1 million settlement to a patient in her transvaginal mesh lawsuit. The lawsuit was filed against Ethicon, the maker of the Gynecare Prolift mesh device, and its parent company Johnson & Johnson, according to a March 26, 2014 article from LawyersandSettlements.com....

2014-03-14 23:04:27

National Law Firm Continues to Advocate for Women Harmed by the Negligence of Pharmaceutical Companies Dallas, TX (PRWEB) March 14, 2014 March is Women’s History Month, and the national law firm of Baron and Budd would like to recognize the incredible contributions women have made to this country. Our firm is committed to fighting for the rights of women who have been harmed due to dangerous pharmaceutical products. The Women’s Health Team at Baron and Budd works passionately to...

2014-02-21 23:03:33

Drug Allgedly Linked to Breast Enlargement in Males DALLAS (PRWEB) February 21, 2014 The national plaintiffs’ law firm of Baron and Budd announces that it is now handling lawsuits relative to the drug Risperdal. Risperdal is prescribed to treat children, adolescents and adults with schizophrenia. Baron and Budd lawyers are working with males who allegedly suffered breast enlargement after taking the drug. Risperdal, manufactured by Johnson & Johnson, was first approved by the Food...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.